z-logo
open-access-imgOpen Access
In vivo correction of cystic fibrosis mediated by PNA nanoparticles
Author(s) -
Alexandra S. Piotrowski-Daspit,
Christina Barone,
Chun-Yu Lin,
Yanxiang Deng,
Douglas H. Wu,
Thomas C. Binns,
Emily Xu,
Adele S. Ricciardi,
Rachael Putman,
Alannah Garrison,
Ruby H.N. Nguyen,
Anisha Gupta,
Rong Fan,
Peter M. Glazer,
W. Mark Saltzman,
Marie E. Egan
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abo0522
Subject(s) - cystic fibrosis , in vivo , cystic fibrosis transmembrane conductance regulator , electroporation , in vitro , mutation , ex vivo , gene delivery , genetic enhancement , chemistry , microbiology and biotechnology , gene , biology , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom